Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-B7489-50 50 µg $485 
SDF1 / CXCL12 Antibody - Anti-CXCL12 antibody IHC of human kidney, tubules. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 2.5 ug/ml.
SDF1 / CXCL12 Antibody - Western Blot (reducing) of SDF-1 / CXCL12 antibody
SDF1 / CXCL12 Antibody - Western Blot (non-reducing) of SDF-1 / CXCL12 antibody
SDF1 / CXCL12 Antibody - Sandwich ELISA of SDF-1 / CXCL12 antibody
SDF1 / CXCL12 Antibody - Anti-CXCL12 antibody IHC of human kidney, tubules. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 2.5 ug/ml.
SDF1 / CXCL12 Antibody - Western Blot (reducing) of SDF-1 / CXCL12 antibody
SDF1 / CXCL12 Antibody - Western Blot (non-reducing) of SDF-1 / CXCL12 antibody
SDF1 / CXCL12 Antibody - Sandwich ELISA of SDF-1 / CXCL12 antibody
1 of 4
2 of 4
3 of 4
4 of 4

IHC‑plus™ Polyclonal Rabbit anti‑Human SDF1 / CXCL12 Antibody (IHC, WB) LS‑B7489

IHC‑plus™ Polyclonal Rabbit anti‑Human SDF1 / CXCL12 Antibody (IHC, WB) LS‑B7489

Note: This antibody replaces LS-C104649, LS-C43001
Antibody:
SDF1 / CXCL12 Rabbit anti-Human Polyclonal Antibody
Application:
IHC, IHC-P, WB, ELISA
Reactivity:
Human
Format:
Unconjugated, Unmodified
Other formats:
Price
Catalog Number
$485
LS-B7489-50
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
SDF1 / CXCL12 Rabbit anti-Human Polyclonal Antibody
Application:
IHC, IHC-P, WB, ELISA
Reactivity:
Human
Format:
Unconjugated, Unmodified
Other formats:

Specifications

Description
CXCL12 antibody LS-B7489 is an unconjugated rabbit polyclonal antibody to human CXCL12 (SDF1). Validated for ELISA, IHC and WB. Tested on 20 paraffin-embedded human tissues.
Target
Human SDF1 / CXCL12
Synonyms
CXCL12 | C-X-C motif chemokine 12 | HIRH | IRH | SDF-1 | SDF-1b | SDF1A | SDF1B | TPAR1 | TLSF-a | TLSF-b | SDF-1a | SDF1 | Sdf1alpha | Stromal cell-derived factor 1 | TLSF | HSDF-1 | PBSF | SCYB12
Host
Rabbit
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG Polyclonal
Conjugations
Unconjugated. Also available conjugated with Biotin.
Purification
Immunoaffinity purified
Modifications
Unmodified
Immunogen
E.coli derived recombinant Human SDF-1alpha.
Specificity
Human SDF-1alpha
Applications
  • IHC
  • IHC - Paraffin (2.5 µg/ml)
  • Western blot (0.1 - 0.2 µg/ml)
  • ELISA (0.5 - 2 µg/ml)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Usage
Immunohistochemistry: LS-B7489 in an IHC-plus antibody, validated by our pathologists for use in IHC against formalin-fixed, paraffin-embedded human tissues (IHC validation procedure). A concentration of 2.5 ug/ml is recommended. Neutralization: To yield one-half maximal inhibition [ND] of the biological activity of Human SDF-1alpha (100 ng/ml), a concentration of 2-4 ug/ml of this antibody is required. ELISA: To detect Human SDF-1alpha by sandwich ELISA (using 100 ul/well antibody solution) a concentration of 0.5-2 ug/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with Biotinylated Anti-Human SDF-1alpha (LS-C104650) as a detection antibody, allows the detection of at least 0.2-0.4 ng/well of recombinant Human SDF-1alpha. Western Blot: To detect Human SDF-1alpha by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 ug/ml. When used in conjunction with compatible secondary reagents, the detection limit for recombinant Human SDF-1alpha is 1.5-3 ng/lane, under either reducing or non-reducing conditions.
Presentation
Lyophilized from PBS, pH 7.2
Reconstitution
Centrifuge the vial before opening. Reconstitute in water to 0.1-1.0 mg/ml. Do not vortex.
Storage
Store Lyophilized at room temperature up to 1 month; Reconstituted for up to 2 weeks at 2°C to 8°C. Aliquot and freeze at -20°C for long term storage. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About SDF1 / CXCL12
P48061 NM_000609 NP_000600.1

Validation

SDF1 / CXCL12 Antibody - Anti-CXCL12 antibody IHC of human kidney, tubules. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 2.5 ug/ml.
Anti-CXCL12 antibody IHC of human kidney, tubules. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 2.5 ug/ml.
Anti-CXCL12 antibody IHC of human kidney, tubules. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 2.5 ug/ml.

LSBio Ratings

IHC-plus™ SDF1 / CXCL12 Antibody for IHC, WB/Western, ELISA LS-B7489 has an LSBio Rating of
Laboratory Validation Score (4)

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/19/2024